MANAGER, EPL WEST COAST, SENIOR PATHOLOGIST
Ted Birkebak received his D.V.M. degree from the University of Florida and his Ph.D. degree from Washington State University. He is certified by the American College of Veterinary Pathologists in anatomical pathology. Currently, Ted is a Senior Pathologist for Experimental Pathology Laboratories (EPL), Inc. Before his position with EPL, Ted spent five years at the University of Washington in Seattle as a postdoctoral fellow and Assistant Professor supporting research and diagnostic activities in the primate center and rodent facility. In 1999, he joined Pharmacia & Upjohn (now Pfizer) where he served as a study pathologist, study director and project team toxicologist. In 2006, he joined Sanofi Aventis (now Sanofi) where he initially supported pathology and toxicology functions, and then became Head of Pathology at the U.S. site in Bridgewater, NJ. He has greater than 20 years of experience supporting the development of small molecules and biologics. In the pharmaceutical industry, he has functioned as a study pathologist, study director, project team toxicologist, and a manager of both toxicology and pathology groups. He has worked on programs from discovery thru post-NDA life cycle management and has experience interacting with U.S. and E.U. regulatory agencies. Ted has conducted the pathology evaluation of studies from early non-GLP thru carcinogenicity assessment and is familiar with all commonly used laboratory species. He has experience in the evaluation and characterization of genetically modified rodents, the identification and development of appropriate animal models, and the design and conduct of pharmacology studies.
Expertise and Interests
- Toxicologic Pathology
- Drug Development Strategies
- Regulatory Interactions
- Non-Human Primate Pathology
- Pathology Peer Reviews